Cinemark Holdings, Inc.
No SEC Form 4 filings for $CNK in the last 30 days.
Cinemark director Mark Zoradi transferred 7,364 shares of Cinemark common stock to a family trust on April 6, 2026, for which he serves as trustee, without receiving any consideration. After this transaction, Zoradi directly holds 4,200 shares and indirectly holds 293,972 shares through the family trust. This gift is categorized as a "bona fide gift" in the SEC Form 4 filing.
Macquarie analyst Chad Beynon has reiterated an 'Outperform' rating for Cinemark Holdings (CNK), maintaining a price target of $36.00. While the stock is considered slightly overvalued at a 4.9% premium based on its GF Value™, it boasts a strong GF Score™ of 83/100, indicating good overall performance potential driven by profitability and growth. However, investors are advised to note recent insider selling activity totalling $206,941.
Cinemark Holdings, Inc. announced its first quarter 2026 earnings results, providing an executive commentary accessible on its Investor Relations website. The company will host a public audio webcast on May 1, 2026, at 8:30 a.m. Eastern Time to discuss these results. Cinemark, a major global theatrical exhibition company, operates nearly 500 theaters across the U.S. and South/Central American countries, offering advanced cinema technologies and amenities.
